[1] |
LIU XJ, CHEN MK. Research advances in portal hypertensive gastropathy[J]. Chin J Dig Endosc, 2020, 37(10): 762-765. DOI: 10.3760/cma.j.cn321463-20191014-00688.
刘小娇, 陈明锴. 门脉高压性胃病研究进展[J]. 中华消化内镜杂志, 2020, 37(10): 762-765. DOI: 10.3760/cma.j.cn321463-20191014-00688.
|
[2] |
ROCKEY DC. An update: Portal hypertensive gastropathy and colopathy[J]. Clin Liver Dis, 2019, 23(4): 643-658. DOI: 10.1016/j.cld.2019.07.002.
|
[3] |
LYLES T, ELLIOTT A, ROCKEY DC. A risk scoring system to predict in-hospital mortality in patients with cirrhosis presenting with upper gastrointestinal bleeding[J]. J Clin Gastroenterol, 2014, 48(8): 712-720. DOI: 10.1097/MCG.0000000000000014.
|
[4] |
WANG WS, CHEN DF, WEN LZ. Highlights in portal hypertensive gastropathy[J]. J Prac Hepatol, 2019, 22(4): 601-604. DOI: 10.3969/j.issn.1672-5069.2019.04.038.
王文生, 陈东风, 文良志. 门脉高压性胃病临床研究进展[J]. 实用肝脏病杂志, 2019, 22(4): 601-604. DOI: 10.3969/j.issn.1672-5069.2019.04.038.
|
[5] |
AMER IF, EL SHENNAWY EM, EL BATEA H, et al. Accuracy of noninvasive tests in the prediction of portal hypertensive gastropathy in Egyptian patients with cirrhosis[J]. JGH Open, 2021, 5(2): 286-293. DOI: 10.1002/jgh3.12486.
|
[6] |
EL-KALLA F, MANSOUR L, KOBTAN A, et al. Blood ammonia level correlates with severity of cirrhotic portal hypertensive gastropathy[J]. Gastroenterol Res Pract, 2018, 2018: 9067583. DOI: 10.1155/2018/9067583.
|
[7] |
NISHINO K, KAWANAKA M, MANABE N, et al. Portal hypertensive gastropathy in liver cirrhosis: Prevalence, natural history, and risk factors[J]. Intern Med, 2022, 61(5): 605-613. DOI: 10.2169/internalmedicine.7943-21.
|
[8] |
MIN YW, BAE SY, GWAK GY, et al. A clinical predictor of varices and portal hypertensive gastropathy in patients with chronic liver disease[J]. Clin Mol Hepatol, 2012, 18(2): 178-184. DOI: 10.3350/cmh.2012.18.2.178.
|
[9] |
YU S, CHEN W, JIANG Z. Platelet count/spleen volume ratio has a good predictive value for esophageal varices in patients with hepatitis B liver cirrhosis[J]. PLoS One, 2021, 16(12): e0260774. DOI: 10.1371/journal.pone.0260774.
|
[10] |
Chinese Society of Hepatology, Chinese Medical Association. Chinese guidelines on the management of liver cirrhosis[J]. J Clin Hepatol, 2019, 35(11): 2408-2425. DOI: 10.3969/j.issn.1001-5256.2019.11.006.
中华医学会肝病学分会. 肝硬化诊治指南[J]. 临床肝胆病杂志, 2019, 35(11): 2408-2425. DOI: 10.3969/j.issn.1001-5256.2019.11.006.
|
[11] |
DE FRANCHIS R. Updating consensus in portal hypertension: report of the Baveno Ⅲ Consensus Workshop on definitions, methodology and therapeutic strategies in portal hypertension[J]. J Hepatol, 2000, 33(5): 846-852. DOI: 10.1016/s0168-8278(00)80320-7.
|
[12] |
BADRAN DH, KALBOUNEH HM, AL-HADIDI MT, et al. Ultrasonographic assessment of splenic volume and its correlation with body parameters in a Jordanian population[J]. Saudi Med J, 2015, 36(8): 967-972. DOI: 10.15537/smj.2015.8.11809.
|
[13] |
MOROZOV SV, IZRANOV VA. Methods of ultrasound spleen morphometry[J]. J Ultrasound Med, 2022, 41(9): 2123-2133. DOI: 10.1002/jum.15901.
|
[14] |
LI Y, WANG ZH, LI PP, et al. 3D visualization technology for measuring the spleen volume of normal Chinese adult[J]. J Hepatobiliary Surg, 2018, 26(5): 340-343. DOI: 10.3969/j.issn.1006-4761.2018.05.007.
李曜, 王志恒, 李鹏鹏, 等. 三维可视化技术测定中国正常成人脾脏体积的研究[J]. 肝胆外科杂志, 2018, 26(5): 340-343. DOI: 10.3969/j.issn.1006-4761.2018.05.007.
|
[15] |
DE FRANCHIS R. Evolving consensus in portal hypertension. Report of the Baveno Ⅳ consensus workshop on methodology of diagnosis and therapy in portal hypertension[J]. J Hepatol, 2005, 43(1): 167-176. DOI: 10.1016/j.jhep.2005.05.009.
|
[16] |
CHEN SY, LIN QY, HUANG XQ. Studies on diagnosis and pathogenesis of portal hypertensive gastropathy[J]. J Diagn Concepts Pract, 2016, 15(5): 451-454. DOI: 10.16150/j.1671-2870.2016.05.003.
陈世耀, 林秋燕, 黄晓铨. 门静脉高压性胃病的诊断及发病机制研究[J]. 诊断学理论与实践, 2016, 15(5): 451-454. DOI: 10.16150/j.1671-2870.2016.05.003.
|
[17] |
DE FRANCHIS R, BOSCH J, GARCIA-TSAO G, et al. Baveno Ⅶ-Renewing consensus in portal hypertension[J]. J Hepatol, 2022, 76(4): 959-974. DOI: 10.1016/j.jhep.2021.12.022.
|
[18] |
SALEEM K, BAIG FA, NIDA M, et al. Correlation between severity of portal hypertensive gastropathy and size of oesophageal varices in cirrhotic hepatitis-C patients[J]. J Ayub Med Coll Abbottabad, 2018, 30(1): 54-57.
|
[19] |
SIMBRUNNER B, BEER A, WÖRAN K, et al. Portal hypertensive gastropathy is associated with iron deficiency anemia[J]. Wien Klin Wochenschr, 2020, 132(1-2): 1-11. DOI: 10.1007/s00508-019-01593-w.
|
[20] |
SUN DY. Prediction of FIB-4、Lok and King score measurement for esophageal varices in cirrhosis[D]. Hefei: Anhui Medical University, 2021.
孙迪一. FIB-4、Lok和King评分对肝硬化食管静脉曲张的预测价值[D]. 合肥: 安徽医科大学, 2021.
|
[21] |
MANDHWANI R, HANIF FM, UL HAQUE MM, et al. Noninvasive clinical predictors of portal hypertensive gastropathy in patients with liver cirrhosis[J]. J Transl Int Med, 2017, 5(3): 169-173. DOI: 10.1515/jtim-2017-0025.
|
[22] |
JIANG A, LI ZF. Common causes and treatment strategies of hyperslenism[J/OL]. Chin J Hepat Surg (Electronic Edition), 2018, 7(2): 97-99. DOI:
蒋安, 李宗芳. 脾功能亢进常见原因及治疗策略[J/OL]. 中华肝脏外科手术学电子杂志, 2018, 7(2): 97-99. DOI:
|